We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Builders FirstSource
BLDR
$7.8B
| $23.2M | 0.05% |
+500,000
| New | +$21.3M |
|
|
SPR
402
DELISTED
Spirit AeroSystems
SPR
| $23.2M | 0.05% |
475,877
-275,151
| -37% | -$11.8M |
|
403
Qorvo
QRVO
$8.41B
| $22.9M | 0.05% |
125,500
-300
| -0.2% | -$52.7K |
|
404
Regeneron Pharmaceuticals
REGN
$79.5B
| $22.9M | 0.05% |
48,406
-52,200
| -52% | -$25.4M |
|
405
Paysafe
PSFE
$385M
| $22.9M | 0.05% |
+141,356
| New | +$22.9M |
|
406
Cintas
CTAS
$80.9B
| $22.9M | 0.05% |
268,000
-300,812
| -53% | -$25.5M |
|
|
MRNS
407
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $22.6M | 0.05% |
1,462,500
| – | – |
|
408
Mid-America Apartment Communities
MAA
$15.5B
| $22.6M | 0.05% |
156,250
+18,100
| +13% | +$2.46M |
|
|
KAIR
409
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
| $22.5M | 0.05% |
+2,310,099
| New | +$22.7M |
|
|
ACTDU
410
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
| $22.5M | 0.05% |
+2,250,000
| New | +$22.5M |
|
411
Take-Two Interactive
TTWO
$43.5B
| $22.5M | 0.05% |
127,219
-823
| -0.6% | -$156K |
|
412
Teradyne
TER
$60.2B
| $22.4M | 0.05% |
183,924
-99,600
| -35% | -$12.5M |
|
413
Roper Technologies
ROP
$39.3B
| $22.3M | 0.05% |
+55,392
| New | +$22.2M |
|
414
Tractor Supply
TSCO
$17.9B
| $22.3M | 0.05% |
629,500
-12,000
| -2% | -$383K |
|
|
OLK
415
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $22.2M | 0.05% |
+617,183
| New | +$20.8M |
|
416
Ventas
VTR
$47.3B
| $22.2M | 0.05% |
416,300
+7,100
| +2% | +$364K |
|
417
Entergy
ETR
$49.7B
| $22.2M | 0.05% |
445,404
-8,400
| -2% | -$397K |
|
|
FTOC
418
DELISTED
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
| $22.1M | 0.05% |
+2,094,908
| New | +$24.6M |
|
|
SWBK
419
DELISTED
Switchback II Corporation
SWBK
| $22.1M | 0.05% |
+2,250,000
| New | +$23M |
|
420
StepStone Group
STEP
$4.14B
| $22.1M | 0.05% |
625,809
+221,358
| +55% | +$7.79M |
|
421
Citizens Financial Group
CFG
$30.5B
| $22.1M | 0.05% |
499,459
-183,900
| -27% | -$7.65M |
|
422
Las Vegas Sands
LVS
$29.9B
| $21.8M | 0.04% |
358,100
-6,900
| -2% | -$404K |
|
|
DISH
423
DELISTED
DISH Network Corp.
DISH
| $21.7M | 0.04% |
600,378
-470,500
| -44% | -$15.7M |
|
424
Rockwell Automation
ROK
$49.2B
| $21.7M | 0.04% |
81,826
-47,201
| -37% | -$12M |
|
|
INZY
425
DELISTED
Inozyme Pharma
INZY
| $21.6M | 0.04% |
1,089,672
+193,000
| +22% | +$4.26M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.